Breaking
Americans Rule Trading
Author

admin

Browsing
Investing

NorthStar Gaming to Host Q2 2025 Earnings Webinar on August 14th

Investing 5 Mins Read

NorthStar Gaming Holdings Inc. (TSXV: BET,OTC:NSBBF) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) announces that it will hold an investor webinar on August 14th at 11:00 am EDT following the release of its results for the second quarter of 2025. The Company expects to announce its financial results and file its condensed consolidated interim financial statements for the three- and six-month periods ended June 30, 2025 and associated management’s discussion and analysis on August 13, 2025.

NorthStar invites all investors and other interested parties to register for the webinar at the link below. Michael Moskowitz, Chairman and CEO, will be presenting the Company’s financial results and an update on current operations and strategic priorities.

Date: Thursday, August 14th, 2025
Time: 11am EDT
Register: Webinar Registration

HAVE QUESTIONS? Management will be available to answer your questions following the presentation on the webinar platform. You may submit your question(s) beforehand in the registration form linked above.

About NorthStar

NorthStar proudly owns and operates NorthStar Bets, a Canadian-born casino and sportsbook platform that delivers a premium, distinctly local gaming experience. Designed with high-stakes players in mind, NorthStar Bets Casino offers a curated selection of the most popular games, ensuring an elevated user experience. Our sportsbook stands out with its exclusive Sports Insights feature, seamlessly integrating betting guidance, stats, and scores, all tailored to meet the expectations of a premium audience.

As a Canadian company, NorthStar is uniquely positioned to cater to customers who seek a high-quality product and an exceptional level of personalized service, setting a new standard in the industry. NorthStar is committed to operating at the highest level of responsible gaming standards.

NorthStar is listed in Canada on the Toronto Stock Venture Exchange under the symbol BET and in the United States on the OTCQB under the symbol NSBBF. For more information on the company, please visit: www.northstargaming.ca.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Information and Statements

This communication contains ‘forward-looking information’ within the meaning of applicable securities laws in Canada (‘forward-looking statements’), including without limitation, statements with respect to the following: expected performance of the Company’s business, and the timing of the release of the Company’s financial results. The foregoing is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and allowing investors and others to get a better understanding of the Company’s anticipated financial position, results of operations, and operating environment. Often, but not always, forward-looking statements can be identified by the use of words such as ‘plans’, ‘expects’, ‘is expected’, ‘budget’, ‘scheduled’, ‘estimates’, ‘continues’, ‘forecasts’, ‘projects’, ‘predicts’, ‘intends’, ‘anticipates’ or ‘believes’, or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘should’, ‘might’ or ‘will’ be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. This forward-looking information is based on management’s opinions, estimates and assumptions that, while considered by NorthStar to be appropriate and reasonable as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such forward- looking information. Such factors include, among others, the following: risks related to the Company’s business and financial position; risks associated with general economic conditions; adverse industry risks; future legislative and regulatory developments; the ability of the Company to implement its business strategies; and those factors discussed in greater detail under the ‘Risk Factors’ section of the Company’s most recent annual information form, which is available under NorthStar’s profile on SEDAR+ at www.sedarplus.com. Many of these risks are beyond the Company’s control.

If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking statements. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents NorthStar’s expectations as of the date specified herein, and are subject to change after such date. However, the Company disclaims any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.

For further information:

Company Contact:

Corey Goodman
Chief Development Officer 
647-530-2387
investorrelations@northstargaming.ca

Investor Relations:

RB Milestone Group LLC (RBMG) 
Northstar@rbmilestone.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261603

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
Investing

Codelco Seeks Partial Restart at El Teniente Mine After Fatal Collapse

Investing 4 Mins Read

Chile’s state-owned copper giant Codelco is seeking approval to restart parts of its flagship El Teniente mine less than a week after a deadly collapse killed six workers and forced a full suspension of operations, according to sources familiar with the matter.

The accident, triggered by a 4.2-magnitude seismic event last Thursday (July 31), halted production at the world’s largest underground copper mine.

Codelco has formally requested Chile’s National Geology and Mining Service (Sernageomin) to allow a partial reopening of the mine, pending approval of safety and technical evaluations, two sources told Reuters.

The cave-in, which was triggered by the earthquake, occurred more than 900 meters underground and initially trapped five miners.

Their bodies were recovered over several days by a rescue team of more than 100 people, including veterans of Chile’s 2010 San José mine rescue. The body of a sixth miner, who was killed at the time of the collapse, was recovered earlier.

“We deeply regret this outcome,” said O’Higgins Region Prosecutor Aquiles Cubillo on Sunday, confirming the final recovery. He offered no additional details on the cause of the collapse, which remains under investigation.

Operations at El Teniente were formally suspended by Sernageomin, Chile’s geology and mining agency, shortly after the incident.

It also instructed Codelco to submit four comprehensive technical reports before any restart can be authorized. The reports must include: an analysis of the collapse’s cause, a recovery plan, an assessment of current fortification systems, and a wider structural evaluation.

While underground mining has stopped, Codelco has maintained limited activity at El Teniente. The company is conducting ongoing maintenance at the processing plant and smelter, including operations at the smelter’s anode furnaces every two hours to keep critical equipment in operable condition.

Codelco said it had responded to three separate information requests from Sernageomin and Chile’s Labor Inspectorate, but added that it could not yet estimate the financial or operational impact of the suspension.

Scrutiny on safety standards

Mining Minister Aurora Williams ordered the temporary cessation of activities at the mine over the weekend. Meanwhile, Energy and Mining Minister Diego Pacheco said on Sunday that Codelco would commission an international audit to understand what went wrong.

“We’re going to commission an international audit to determine what we did wrong,” Pacheco said. While no formal complaints had been received about the safety conditions of the site, he pledged that a full investigation and appropriate corrective measures are underway.

El Teniente, located about 100 kilometers south of Santiago in the Andes mountains, is a cornerstone of Codelco’s operations and Chile’s mining economy.

It produced 356,000 metric tons of copper in 2024, nearly 7 percent of the country’s total output. The mine has operated for over a century and contains a labyrinth of more than 4,500 kilometers (2,800 miles) of tunnels.

The seismic event that triggered the collapse, while relatively mild by global standards. has raised questions about the structural integrity of older sections of the mine and the adequacy of current fortification systems.

A blow to expansion efforts

The accident is a significant setback for Codelco as it seeks to modernize its aging infrastructure and boost production after years of underinvestment.

The collapsed area is believed to be part of the Andesita section of the mine, a relatively small but strategically important component of El Teniente’s broader expansion, which includes the Andes Norte and Diamante projects.

The Andesita development is intended to help offset declines in older zones and maintain output levels through the next decade. Its disruption will likely ripple through Codelco’s project pipeline, which is already under pressure due to rising costs.

Though Chile boasts one of the world’s safest mining sectors – a fatality rate of just 0.02 percent in 2024 – the string of incidents at Codelco sites has drawn concern from unions and regulators alike.

The industry’s worst accident remains the 1945 fire at El Teniente, which killed 355 miners and stands as one of the deadliest mining disasters in history.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Business

Tim Cook to join Trump at White House for Apple investment announcement

Business 2 Mins Read

Apple CEO Tim Cook will join President Donald Trump on Wednesday for an event touting what the White House calls a new $100 billion investment commitment by the tech giant in the U.S.

The announcement in the Oval Office, set for 4:30 p.m. ET, includes Apple’s commitment to a new “American Manufacturing Program,” a White House official confirmed to CNBC.

With the new pledge, Apple’s total investment in the U.S. over the next four years now totals $600 billion, the official said.

Bloomberg first reported Apple’s new investment pledge earlier Wednesday.

The meeting comes as Trump has pushed Apple to make its products in America — a feat that experts say would jack up prices by hundreds of dollars, if it can even be done at all.

Most of Apple’s flagship iPhones have been manufactured in China, though the company is moving some of its production to India.

Trump has complained about that plan. “We’re not interested in you building in India, India can take care of themselves … we want you to build here,” Trump said he told Cook in May.

On Wednesday, Trump announced he will double the U.S. tariff rate on Indian goods to 50%. Trump said he was raising the tariff because of India continuing to purchase Russian oil.

Trump had exempted smartphones, chips and other tech products from his early April “reciprocal” tariff plan, which slapped a 10% baseline duty on nearly the entire world and set significantly higher rates for dozens of individual countries.

That exemption still applied as of this week, following Trump’s executive order tweaking U.S. tariffs on a slew of countries.

And it appears to remain intact in Trump’s latest order ratcheting up tariffs on imports from India.

Apple declined CNBC’s request for comment.

— CNBC’s Steve Kovach contributed to this report.

This post appeared first on NBC NEWS

Keep Reading
Investing

Crypto Market Update: Bitcoin ETFs Shed US$1.46B Amid Stagflation Jitters

Investing 4 Mins Read

Here’s a quick recap of the crypto landscape for Wednesday (August 6) as of 9:00 a.m. UTC.

Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.

Bitcoin and Ethereum price update

Bitcoin (BTC) was priced at US$114,217, down by 0.8 percent over the last 24 hours. Its highest valuation on Wednesday was US$112,770, while its lowest valuation was US$114,830.

Bitcoin price performance, August 6, 2025.

Chart via TradingView

Bitcoin is showing signs of support between US$117,000 and US$118,000, with technical analysts suggesting a possible rebound toward resistance levels at US$120,250 and beyond, if bullish momentum builds.

However, sentiment remains cautious amid ongoing interest rate uncertainty, macroeconomic pressures and ETF outflows, all of which are weighing on near-term price action.

Ethereum (ETH) was priced at US$3,619.63, down by 1.4 percent over the past 24 hours. Its lowest valuation on Wednesday was US$3,557.78, and its highest was US$3,673.

Altcoin price update

  • Solana (SOL) was priced at US$164.44, down by 3.9 percent over 24 hours. Its lowest valuation on Wednesday was US$161.45, and its highest was US$170.84.
  • XRP was trading for US$2.95, down by 3.8 percent in the past 24 hours. Its lowest valuation of the day was US$2.91, and its highest valuation was US$3.06.
  • Sui (SUI) is trading at US$3.41, down 4.2 percent over the past 24 hours. Its lowest valuation of the day was US$3.34, and its highest was US$3.55.
  • Cardano (ADA) was trading at US$0.7274, down by 3.2 percent over 24 hours. Its lowest valuation on Wednesday was US$0.7117, and its highest was US$0.751.

Today’s crypto news to know

Bitcoin ETFs see four days of outflows as stagflation fears ramp up

Spot bitcoin ETFs in the US recorded net outflows for the fourth day in a row, shedding nearly US$200 million on Tuesday alone.

Fidelity’s FBTC and BlackRock’s IBIT were the biggest sources of withdrawals, contributing to a total outflow of US$1.46 billion since last Thursday.

The trigger appears to be rising concerns around stagflation, following weaker-than-expected US service sector data.

The ISM Non-Manufacturing PMI pointed to slowing growth, declining employment, and rising prices, which represents a toxic mix for risk assets like crypto and tech stocks.

Bitcoin slipped below US$113,000 before recovering slightly, while the Nasdaq also dropped 0.7 percent on the day.

Meanwhile, bets on Federal Reserve rate cuts are growing, but uncertainty remains high.

SBI Files Japan’s first Bitcoin–XRP ETF application

Japanese financial giant SBI Holdings has filed for an ETF that includes both Bitcoin and XRP, aiming to offer regulated dual-crypto exposure in Japan.

The proposed product, revealed in SBI’s Q2 earnings report, would allow investors to track the performance of both assets in a single fund, a rare pairing in the global ETF space.

A second ETF proposal, the Digital Gold Crypto ETF, blends over 50% exposure to traditional gold ETFs with crypto assets backed by gold. This hybrid structure targets more conservative investors looking for crypto upside with commodity stability.

If approved, this would mark the first time XRP is included in a regulated ETF product in Japan, as it continues to face institutional barriers in the US due to its regulatory history.

Liquid staking is not a securities offering — SEC clarifies

In a major development for the crypto industry, the SEC’s Division of Corporation Finance stated that certain types of liquid staking do not constitute the sale of securities, according to a statement.

Specifically, tokenized staking receipt products, such as staked ETH derivatives, are not considered investment contracts unless they’re bundled into schemes that meet the legal definition.

This clarification provides a green light for platforms offering protocol-level staking services without requiring registration. Liquid staking allows users to earn rewards while still being able to trade or use a representative token, maintaining asset flexibility.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Investing

Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis

Investing 9 Mins Read

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol‘ or the ‘Company‘), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announced topline results from ARCHER, the Company’s Phase II clinical trial in patients with acute myocarditis. In the two primary endpoints—extracellular volume (‘ECV’) and global longitudinal strain (‘GLS’)—CardiolRx showed a notable improvement in ECV (p = 0.0538) compared to placebo following 12 weeks of double-blind therapy, with no significant difference observed in GLS in a population that had preserved left ventricular (‘LV’) function at baseline. The reduction in ECV was associated with improvements over placebo in multiple pre-specified cardiac magnetic resonance imaging (‘CMR’) endpoints, including a significant reduction in LV mass. The ARCHER trial results provide compelling clinical proof of concept for CardiolRx and strongly support advancing the clinical development of CardiolRx and CRD-38 in cardiomyopathies, heart failure, and myocarditis. Consistent with findings from Cardiol’s Phase II MAvERIC trial in recurrent pericarditis, CardiolRx was shown to be safe and well tolerated. The ARCHER results have been submitted for presentation at an upcoming scientific meeting and will be submitted for publication.

  • Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring CardiolRx over placebo.
  • Reduction in ECV was associated with improvements across multiple pre-specified cardiac magnetic resonance imaging (CMR) endpoints, including a significant reduction in LV mass.
  • The ARCHER trial results provide compelling clinical proof of concept for CardiolRx and strongly support advancing the clinical development of CardiolRx and CRD-38 in cardiomyopathies, heart failure, and myocarditis.
  • The ARCHER results have been submitted for presentation at an upcoming scientific meeting and will be submitted for publication.

‘On behalf of the ARCHER Steering Committee, I would like to extend our sincere gratitude to the patients who participated in the study; to their families and caregivers for their invaluable support; and to the clinical trial site investigators and staff, members of the international Steering Committee, and the Data and Safety Monitoring Committee, whose exemplary efforts in patient recruitment, clinical care, trial execution, monitoring, and oversight were instrumental in achieving the compelling findings of the ARCHER trial,’ said Dr. Dennis M. McNamara, Professor of Medicine at the University of Pittsburgh, Director of the Center for Heart Failure Research at the University of Pittsburgh Medical Center, and Chair of the ARCHER Steering Committee. ‘I commend Cardiol for undertaking this important trial that investigated the biological effects of pharmaceutically manufactured cannabidiol in acute myocarditis. The results offer exciting new insights into the treatment of acute myocarditis and strongly support advancing the clinical development of this novel therapeutic approach for inflammatory cardiac conditions, including myocarditis and heart failure. I look forward to collaborating with my colleagues on the Steering Committee as we prepare for the presentation and publication of the comprehensive ARCHER trial data.’

Dr. Leslie T. Cooper, Jr., the Elizabeth C. Lane, Ph.D. and M. Nadine Zimmerman, Ph.D. Professor of Internal Medicine at the Mayo Clinic in Jacksonville, Florida, and Co-Chair of the Steering Committee for the ARCHER trial, added, ‘ARCHER was an important, well-designed, and well-executed clinical trial. The intriguing findings reinforce our original hypothesis that pharmaceutically manufactured cannabidiol can attenuate myocardial inflammation and edema. ARCHER’s results provide sound rationale for advancing the clinical development of this novel therapy in conditions of the myocardium characterized by edema, fibrosis, and remodeling, including the growing challenge of immune checkpoint inhibitor-induced myocarditis which can be fatal.’

‘We are delighted with the ARCHER trial results,’ said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics. ‘We initiated this ambitious study—focused on a potentially life-threatening cardiac disorder for which there is no established standard of care—to further investigate the therapeutic potential of CardiolRx in inflammatory heart disease. We are thrilled to observe improvements in multiple CMR measures associated with diagnosis, prognosis, and clinical outcomes. As we continue to advance our lead clinical program, the pivotal Phase III MAVERIC trial in recurrent pericarditis, we now look forward to integrating the ARCHER findings into our broader clinical development strategy and business development initiatives—supporting the continued advancement of CardiolRx and CRD-38 as potential treatments for inflammatory cardiac disorders.’

ARCHER is a Phase II multi-national, randomized, double-blind, placebo-controlled trial investigating the safety, tolerability, and impact of CardiolRx on myocardial recovery in patients presenting with acute myocarditis. The design and rationale for ARCHER were published on June 27, 2024, in the journal ESC Heart Failure. The study enrolled 109 patients from leading cardiovascular research centers in the United States, France, Brazil, and Israel. The two primary outcome measures of the trial, which were evaluated following 12 weeks of double-blind therapy, consist of cardiac magnetic resonance imaging parameters: extra-cellular volume and global longitudinal strain, which assess myocardial function and tissue characteristics associated with fibrosis and inflammation.

Acute Myocarditis

Acute myocarditis is an inflammatory condition of the heart muscle (myocardium) characterized by chest pain, shortness of breath at rest or during activity, fatigue, rapid or irregular heartbeat (arrhythmias), and light-headedness or the feeling one might faint. The disease is an important cause of acute and fulminant heart failure and is a leading cause of sudden cardiac death in people under 35 years of age. Viral infection is the most common cause of myocarditis; however, it can also result from bacterial infection, commonly used drugs, and mRNA vaccines, as well as therapies used to treat several common cancers, including chemo-therapeutic agents and immune checkpoint inhibitors. There are no FDA-approved drug therapies for acute myocarditis. Patients hospitalized with the condition experience an average seven-day length of stay and a 4 – 6% risk of in-hospital mortality, with average hospital charge per stay estimated at $110,000 in the United States.

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead small molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure.

Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration (‘US FDA’) to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart: recurrent pericarditis and acute myocarditis. The MAVERIC Program in recurrent pericarditis, an inflammatory disease of the pericardium which is associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, and results in physical limitations, reduced quality of life, emergency department visits, and hospitalizations, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing Phase III MAVERIC trial (NCT06708299). The completed ARCHER trial (NCT05180240) is a Phase II study in acute myocarditis, an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in people less than 35 years of age. The US FDA has granted Orphan Drug Designation to CardiolRx for the treatment of pericarditis, which includes recurrent pericarditis.

Cardiol is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure—a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.

For more information about Cardiol Therapeutics, please visit cardiolrx.com.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward-looking information contained herein may include, but is not limited to statements regarding the Company’s focus on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, the Company’s intended clinical studies and trial activities and timelines associated with such activities, including the Company’s plan to complete the Phase III study in recurrent pericarditis with CardiolRx, the Company’s plan to advance the development of CRD-38, a novel subcutaneous formulation of cannabidiol intended for use in heart failure, the Company’s presentation and publication of the comprehensive ARCHER trial data, and the Company’s belief that results from the ARCHER trial provide compelling clinical proof of concept for CardiolRx and strongly support advancing the clinical development of CardiolRx and CRD-38 for the treatment of inflammatory cardiac disorders including cardiomyopathies, heart failure, and myocarditis. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Information Form filed with the Canadian securities administrators and U.S. Securities and Exchange Commission on March 31, 2025, available on SEDAR+ at sedarplus.ca and EDGAR at sec.gov, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements.

For further information, please contact:
Trevor Burns, Investor Relations +1-289-910-0855
trevor.burns@cardiolrx.com

Click here to connect with Cardiol Therapeutics Inc. to receive an Investor Presentation

Source

This post appeared first on investingnews.com

Keep Reading
Investing

Seismic Equipment Arrives For Enercam Resources’ Oil & Gas Block VIII, Cambodia

Investing 5 Mins Read

(TheNewswire)

GRANDE PRAIRIE, ALBERTA – August 6, 2025 TheNewswire – Angkor Resources Corp. (TSXV: ANK,OTC:ANKOF) (‘ANGKOR’ OR ‘THE COMPANY’) announces its subsidiary, EnerCam Resources Co. Ltd. (Cambodia) (‘EnerCam’) has landed seismic equipment from seismic contractor GeneSeis Company Limited Thailand (‘GeneSeis’) to commence Cambodia’s first onshore EnviroVibe oil and gas seismic for Block VIII (‘Project’).

Keith Edwards, Technical Manager of EnerCam, comments on the start of this type of seismic, ‘This program will provide comprehensive coverage over Block VIII and will guide our efforts going forward.  We are excited about this search for Cambodia’s first site for onshore oil and gas production and hopefully this seismic will lead to the first onshore well being drilled in Cambodia.’

Due to border conflict issues which started in May and ceasefire agreements in late July, the equipment could not pass through land borders and therefore, five containers came into Sihanoukville port by ship and then were transported to the base camp of the seismic program.

Seismic teams are executing 350-line kilometers of two dimensional seismic over four identified sub basins on the west side of the license area plus a newly described ‘mussel basin’ on the northeast side of the license.

Mike Weeks, President of EnerCam, states, ‘We are very pleased to be starting this seismic program on Block VIII; it is a huge milestone for both the company and the country.   Overcoming the hurdles is a tribute to the team and we are expecting to see this program provide significant data towards drill targets for Cambodia’s onshore oil and gas industry.’

Following a multitude of scoping missions by the lead geoscientists of EnerCam, accompanied by graduate students from Institute of Technology of Cambodia (ITC) and logistics manager Bunchhay Yun, the team now prepares to start an environmentally friendly seismic program in the Kingdom of Cambodia.   Keith Edwards, Technical Manager for EnerCam explains, ‘The EnviroVibe units use no dynamite but instead use the weight of the vehicle and a hydraulicly controlled vibrating pad to send acoustic (sound) waves into the sub-surface.   This vibration is done with frequencies of 3-80Hz, 3 times for 12 seconds each time using two EnviroVibe vehicles that are synchronized.  By spreading the energy over 36 seconds, we can operate in many environments with no negative impacts.’

Management is expecting noise from rainfall or traffic to have less impact on the VibroSeis data than traditional impulsive sources such as dynamite or weight drop.  Specific plans were made on access points to mitigate this and recent adjustments incorporated that into the planned program.

The teams have driven over 3720 kilometers, spent several weeks between May and July confirming the best routes to take for quality data, and have taken over 2900 photos of terrain as part of the data collection prior to seismic lines.

Between 35-40 personnel are now deployed to execute the 2-D seismic over the verified roads and access points.  All affected landowners, community and commune authorities have been contacted and have given permission for EnerCam to proceed. The program started yesterday and is expected to take a minimum of four weeks to cover the destination routes to acquire the necessary data.


Click Image To View Full Size


Click Image To View Full Size

Figure 1  Mike Weeks in foreground of Envirovibe machine and several staff sorting

through some of the 2000+ geophones.

Figure 2:  Over 2000 geophones, which convert ground movement into voltage, form part of  the equipment for the 350 line kilometers from which vibrations will be measured.


Click Image To View Full Size

Figure 3 New Oil Seeps identified on most the recent Scouting Mission on July 29 2025.

ABOUT Angkor Resources CORPORATION:

Angkor Resources Corp. is a public company, listed on the TSX-Venture Exchange, and is a leading resource optimizer in Cambodia working towards mineral and energy solutions across Canada and Cambodia. ANGKOR’s carbon capture and gas conservation project in Saskatchewan, Canada is part of its long-term commitment to Environmental and Social projects and cleaner energy solutions across jurisdictions.  The company’s mineral subsidiary, Angkor Gold Corp. in Cambodia holds three mineral exploration licenses in Cambodia and its Cambodian energy subsidiary, EnerCam Resources, was granted an onshore oil and gas license of 7300 square kilometers in the southwest quadrant of Cambodia called Block VIII.   The company then removed all parks and protected areas to reduce the size to just over 3700 square kilometers.   Since 2022, Angkor’s Canadian subsidiary, EnerCam Exploration Ltd., has been involved in gas/carbon capture and oil and gas production in Saskatchewan, Canada.

CONTACT: Delayne Weeks – CEO

Email: info@angkorresources.com Website: angkor resources.com Telephone: +1 (780) 831-8722

Please follow @AngkorResources on , , , Instagram and .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to the potential for gold and/or other minerals at any of the Company’s properties, the prospective nature of any claims comprising the Company’s property interests, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, uncertainty of sample results, timing and results o f future exploration, and the availability of financing.  Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

Copyright (c) 2025 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
Investing

First Quantum Secures US$1 Billion in Gold Stream Deal with Royal Gold

Investing 4 Mins Read

First Quantum Minerals (TSX:FM,OTC Pink:FQVLF) has locked in a US$1.0 billion cash infusion through a gold streaming agreement with RGLD Gold AG, a wholly owned subsidiary of Royal Gold (NASDAQ:RGLD).

The Vancouver-based firm announced on Tuesday (August 5) that the streaming agreement is tied to its Zambian operations, covering future gold deliveries linked to copper output at its Kansanshi mine.

“Following a thorough evaluation of several deleveraging options, I am pleased to announce this milestone transaction which preserves exposure to all of the copper production at Kansanshi while still maintaining exposure to the majority of the Company’s gold production,” said First Quantum CEO Tristan Pascall in a press release.

“It is pleasing to form a new partnership with Royal Gold which is a strong endorsement of the operations at Kansanshi and its multi-generational ore body as well as Zambia as a leading African mining jurisdiction,” Pascall added.

The agreement provides First Quantum with long-term, unsecured capital that does not increase its debt load. Proceeds will be used for capital expenditures and repayment of existing bank loans. Furthermore, the company said that the transaction is expected to materially lower its net debt-to-EBITDA ratio.

While the arrangement commits First Quantum to deliver gold based on a formula tied to copper production, the company retains most of its gold upside.

Based on its 2026 and 2027 production forecasts, approximately 84 percent of its total gold output will still be exposed to spot market pricing. The company also retains full exposure to newly discovered near-surface gold zones at Kansanshi.

Under the terms of the agreement, First Quantum will deliver gold to Royal Gold on a stepdown basis: 75 ounces of gold for every million pounds of recovered copper produced until 425,000 ounces have been delivered, 55 ounces per million pounds for the next 225,000 ounces, and 45 ounces per million pounds thereafter.

First Quantum will receive 20 percent of the spot gold price per ounce delivered, rising to 35 percent if it secures a BB credit rating or maintains a net leverage ratio of 2.25x or lower for three straight quarters starting Q1 2026.

The deal also includes two optional acceleration provisions, allowing First Quantum to reduce future delivery commitments. The company can cut delivery thresholds by up to 20 percent at a value of up to US$200 million once it reaches the BB rating or leverage target.

A further 10 percent reduction, worth US$100 million, is possible upon achieving a leverage ratio of 1.25 times over four consecutive quarters, subject to meeting certain operational conditions.

The gold streaming deal is part of First Quantum’s continued efforts to strengthen its finances after recent setbacks at the Cobre Panamá mine.

In May, the company announced it had received government approval in Panama for its Preservation and Safe Management program at the Cobre Panamá mine. The approval enables the company to carry out environmental and safety measures funded through the export of 121,000 dry metric tons of copper concentrate currently stored on site.

The program does not represent a restart of full operations, but allows First Quantum to maintain the site and manage its obligations in line with Panamanian government requirements.

On the other hand, the deal also deepens Royal Gold’s exposure to a major African copper-gold asset at a time when the streaming and royalty company is making moves to expand its portfolio.

Just last month, Royal Gold announced a pair of major acquisitions: a US$3.5 billion all-share deal to acquire Sandstorm Gold (TSX:SSL)and a separate US$196 million cash deal for Horizon Copper (TSXV:HCU).

The transactions, announced in July, would create a streaming and royalty giant with 393 assets across six continents—including 80 that are currently cash-flowing.

Shares of First Quantum were up slightly in Tuesday trading following the announcement.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Investing

Uranium Energy’s Sweetwater Project Fast-Tracked Under Trump Initiative

Investing 3 Mins Read

In the latest show of federal support for domestic uranium production, Uranium Energy (NYSEAMERICAN:UEC) Sweetwater uranium complex in Wyoming has been designated for expedited permitting under the Trump administration’s FAST-41 initiative.

The designation, announced August 5, places Sweetwater on the Federal Permitting Improvement Steering Council’s FAST-41 dashboard, a move that aims to accelerate environmental reviews and interagency approvals under a framework established by the 2015 Fixing America’s Surface Transportation (FAST) Act.

The initiative is part of the Trump administration’s strategy to revitalize the US nuclear fuel supply chain and reduce reliance on imports from geopolitical rivals.

“Sweetwater’s selection under FAST-41 reinforces its national importance as a key project to achieve the United States’ goals of establishing reliable infrastructure, supporting nuclear fuel independence,” said UEC President and CEO Amir Adnani in a statement.

“On completing this tack-on permitting initiative, Sweetwater will be the largest dual-feed uranium facility in the United States, licensed to process both conventional ore and ISR resin.”

Located in Wyoming’s Great Divide Basin, the Sweetwater complex is anchored by a fully licensed conventional uranium mill with a capacity of 3,000 metric tons per day and a licensed annual output of 4.1 million pounds.

The site previously included several permitted mines—Sweetwater (Red Desert), Big Eagle, and Jackpot (Green Mountain)—that were approved for conventional methods but will now be evaluated for In-Situ Recovery (ISR) mining, a lower-impact extraction technique.

The new permitting push will allow UEC to modify existing approvals to incorporate ISR capabilities both within and beyond the current mine boundary, including on adjacent federal lands managed by the Bureau of Land Management (BLM).

The BLM, under the Department of the Interior, is the lead permitting agency for the initiative.

“This will provide the Company unrivaled flexibility to scale production across the Great Divide Basin, leveraging UEC’s leading domestic resource base,” Adnani added.

Sweetwater is the second uranium project to receive fast-track treatment under the new policy, following Anfield Energy TSXV:AEC,OTCQB:ANLDF) Velvet-Wood project in Utah, which was granted the status in May.

Velvet-Wood was the first uranium asset to be placed on the FAST-41 dashboard. It is expected to supply uranium for both civilian nuclear energy and defense applications, as well as vanadium, a strategic metal used in batteries and alloys.

Anfield’s Velvet-Wood received accelerated environmental review under a January 20 declaration by President Trump, which cited a national energy emergency and called for urgent steps to restore American energy independence. According to Anfield, the review timeline was cut from what could have taken years to just 14 days.

Taken together, the two fast-tracked uranium projects are a display of a wider federal pivot toward rebuilding a domestic nuclear supply chain, which has withered in recent decades amid low prices and competition from Russia, China, and other state-backed producers.

“I am excited to welcome the Sweetwater Complex to the FAST-41 transparency dashboard in support of President Trump’s goal of unlocking America’s mineral resources,” said Emily Domenech, Executive Director of the Federal Permitting Improvement Steering Council.

The White House confirmed in April that 10 mining projects had been selected so far under the initiative, covering minerals such as copper, gold, lithium, phosphate, potash, and uranium.

With Sweetwater, UEC will operate three hub-and-spoke uranium platforms in the United States: one in South Texas, another in Wyoming’s Powder River Basin, and the Sweetwater Complex in the Great Divide Basin.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
Business

Amazon lays off over 100 employees in Wondery unit as part of audio business restructuring

Business 2 Mins Read

Amazon is laying off roughly 110 employees in its Wondery podcast division and the head of the group is leaving as part of a broader reshuffling of the company’s audio unit.

In a Monday note to staffers, Steve Boom, Amazon’s vice president of audio, Twitch and games, said the company is consolidating some Wondery units under its Audible audiobook and podcasting division. Wondery CEO Jen Sargent is also stepping down from her role, Boom said.

“These changes will not only better align our teams as they work to take advantage of the strategic opportunities ahead but, even more crucially, will ensure we have the right structure in place to deliver the very best experience to creators, customers and advertisers,” Boom wrote in the memo, which was viewed by CNBC. “Unfortunately, these changes also include some role reductions, and we have notified those employees this morning.”

Bloomberg was first to report on the job cuts.

The move comes nearly five years after Amazon acquired Wondery as part of a push to expand its catalog of original audio content. The podcasting company made a name for itself with hit shows like “Dirty John” and “Dr. Death.”

More recently, Wondery signed several lucrative licensing deals with Jason and Travis Kelce’s “New Heights” podcast, along with Dax Shepard’s “Armchair Expert.”

Amazon is streamlining “how Wondery further integrates” into the company by separating the teams that oversee its narrative podcasts from those developing “creator-led shows,” Boom wrote.

The narrative podcasting unit will consolidate under Audible, and creator-led content will move to a new unit within Boom’s organization in Amazon called “creator services,” he wrote.

Amazon’s audio pursuits face a heightened challenge from the growing popularity of video podcasts on Alphabet’s YouTube, which now hosts an increasing number of shows.

Video shows require different discovery, growth and monetization strategies than “audio-first, narrative series,” Boom wrote in the memo to Amazon staffers.

“The podcast landscape has evolved significantly over the past few years,” Boom said.

This post appeared first on NBC NEWS

Keep Reading
Business

U.S. farm agency allows six more states to bar some items from food aid

Business 2 Mins Read

WASHINGTON — The Agriculture Department allowed six additional states Monday to bar participants in the Supplemental Nutrition Assistance Program from using their benefits to buy certain processed foods, such as sodas and candy.

The SNAP waivers for West Virginia, Florida, Colorado, Louisiana, Oklahoma and Texas amend the statutory definition of food for purchase and put an end to the subsidization of popular types of junk food beginning in 2026.

The administration of President Donald Trump has encouraged all states to take such measures as part of its “Make America Healthy Again” initiative, named for the social movement led by Health Secretary Robert F. Kennedy Jr.

The USDA had so far signed waivers to allow six states — Arkansas, Idaho, Utah, Iowa, Indiana and Nebraska — to place similar purchasing restrictions on SNAP recipients.

“I hope to see all 50 states join this bold commonsense approach. For too long, the root causes of our chronic disease epidemic have been addressed with lip service only,” said the U.S. Food and Drug Commissioner Marty Makary.

Agriculture Secretary Brooke Rollins announced the additional waivers at an event at the USDA headquarters in Washington.

“These state waivers promote healthier options for families in need,” said Secretary Rollins.

More than 42 million people receive SNAP benefits, sometimes called food stamps, as part of the nation’s largest anti-hunger program.

The massive tax cut and spending bill signed by President Trump in July makes significant changes to the SNAP program, including expanding work requirements and shifting more spending for the program to states.

This post appeared first on NBC NEWS

Keep Reading